Inventor
Tarek Suhayl Mansour
Inventor
New City, NY, US
Overview
Patents· 41 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes15%
C07HSugars9%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C07BGeneral methods of organic chemistry2%
Y02PClimate change mitigation technologies in the production or processing of goods2%
PatentTitleYear
10,844,0381,2-dithiolane compounds useful in neuroprotection, autoimmune and cancer diseases and conditions202010,351,5401,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions201910,246,4441,2-dithiolane and dithiol compounds useful in treating mutant EGFR-mediated diseases and conditions201910,022,381Triazine compounds as PI3 kinase and mTOR inhibitors20189,487,535'Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents'20169,174,963'Triazine compounds as PI3 kinase and MTOR inhibitors'20158,859,542'Triazine compounds as PI3 kinase and mTOR inhibitors'20148,748,421'Triazine compounds as P13 kinase and MTOR inhibitors'20148,575,159'Triazine compounds as PI3 kinase and mTOR inhibitors'20138,445,486'Triazine compounds as PI3 kinase and mTOR inhibitors'20138,217,036'Triazine compounds as PI3 kinase and mTOR inhibitors'20128,101,590'9-aminocarbonylsubstituted derivatives of glycylcyclines'20128,039,469'Triazine compounds as PI3 kinase and mTOR inhibitors'20117,998,965'Glutamate aggrecanase inhibitors'20117,812,008'9-substituted tetracyclines'20107,812,014'Bicyclic 6-alkylidene-penems as β-lactamase inhibitors'20107,691,842'Tricyclic 6-alkylidene-penems as β-lactamase inhibitors'20107,632,838'11-beta HSD1 inhibitors'20097,553,873'Glutamate aggrecanase inhibitors'20097,276,611'Process for synthesizing beta-lactamase inhibitor intermediates'20077,229,983'4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors'20077,112,582'Bicyclic 6-alkylidene-penems as β-lactamase inhibitors'20067,018,997'Tricyclic 6-alkylidene-penems as β-lactamase inhibitors'20066,831,174'Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties'20046,649,756'PROCESS IMPROVEMENT IN THE PREPARATION OF (4R, 5S, 6S)-3-(2R,3R)-2-(S)-2-AMINO-3-METHYL-1-OXOBUTYLAMINOMETHYLTETRAHYDRO-3-FURANYLTHIO-6-(R)-1-HYDROXYETHYL-4-METHYL-7-OXO-1-AZABICYCLO3.2.0HEPT-2-ENE-2-CARBOXYLIC ACID'20036,369,066'Substituted 1,3-oxathiolanes with antiviral properties'20026,228,860'Substituted 1,3-oxathiolanes with antiviral properties'20016,175,008'Processes for preparing substituted 1,3-oxathiolanes with antiviral properties'20016,156,737'Use of dideoxy nucleoside analogues in the treatment of viral infections'20006,069,250'Method and compositions for the synthesis of dioxolane nucleosides with .beta.-configuration'20005,945,431'Cytomegalovirus inhibiting compounds'19995,922,867'Method and compositions for the synthesis of dioxolane nucleosides with .beta. configuration'19995,763,606'Stereoselective synthesis of nucleoside analogues using bicyclic intermediate'19985,756,706'Processes for the diastereoselective synthesis of nucleoside analogues'19985,744,596'Nucleoside analogues and synthetic intermediates'19985,696,254'Processes for the diastereoselective synthesis of nucleoside analogues'19975,693,787'Intermediates in the synthesis of 1,3-oxathiolanyl cytosine nucleoside analogues'19975,684,164'Processes for preparing substituted 1,3-oxathiolanes with antiviral properties'19975,663,320'Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates'19975,587,480'Substituted 1,3-oxathiolanes and substituted 1,3-dithiolanes with antiviral properties'19965,466,806'Processes for preparing substituted 1,3-oxathiolanes with antiviral properties'1995Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1995–2002Patents assigned to IAF BIOCHEM INT (15)· patent assignee history
1995–2004Based in Montreal, CA· patent location history
2003–2020Based in New City, NY, US· patent location history
2006–2009Patents assigned to WYETH CORP (6)· patent assignee history
2010–2018Patents assigned to WYETH LLC (13)· patent assignee history
2012–2013Patents assigned to MANSOUR TAREK SUHAYL (3)· patent assignee history
2013–2018Patents assigned to PFIZER (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IAF BIOCHEM INT | 15 | 1995–2002 |
| WYETH LLC | 13 | 2010–2018 |
| WYETH CORP | 6 | 2006–2009 |
| MANSOUR TAREK SUHAYLself | 3 | 2012–2013 |
| PFIZER | 3 | 2013–2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| New City, New York, US | 24 | 2003–2020 |
| Montreal, CA | 17 | 1995–2004 |